-
Published 4/1/2026
Barmettler G, Leonard S, Giannakou A, Park KU, Smith CE, Mittendorf EA, King TA, Kantor O. ASO Visual Abstract: Breast Cancer Presentation and Treatment Patterns in Sexual and Gender Minorities. Ann Surg Oncol. 2026 Apr; 33(4):3405-3406. PMID: 41572120.
-
Published 12/11/2025
Barmettler G, Leonard S, Giannakou A, Park KU, Smith CE, Mittendorf EA, King TA, Kantor O. Breast Cancer Presentation and Treatment Patterns in Sexual and Gender Minorities. Ann Surg Oncol. 2026 Apr; 33(4):3302-3310. PMID: 41381928.
-
Published 6/2/2023
Olivier T, Smith CEP, Haslam A, Addeo A, Prasad V. Quality of life in the adjuvant setting: A meta-analysis of US Food and Drug Administration approved anti-cancer drugs from 2018 to 2022. J Cancer Policy. 2023 Sep; 37:100426. PMID: 37270063.
-
Published 9/10/2022
Smith CEP, Marcom PK, Mitri Z, Ko NY. Predictors of long-term durable response in de novo HER2-positive metastatic breast cancer and the real-world treatment experience at two institutions. Breast Cancer Res Treat. 2022 Nov; 196(1):215-220. PMID: 36087190.
-
Published 6/2/2022
Abd El-Salam MA, Smith CEP, Pan CX. Insights on recent innovations in bladder cancer immunotherapy. Cancer Cytopathol. 2022 Sep; 130(9):667-683. PMID: 35653623.